🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Ovarian PRP for Diminished Ovarian Reserve

RecruitingNAAges 35 Years - 42 YearsFemaleGeneration Next Fertility
NCT05790655 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinical diagnosis of diminished ovarian reserve * Clinical diagnosis of poor ovarian response * Women age 35-42 Exclusion Criteria: * Clinical diagnosis of premature ovarian failure * Clinical diagnosis of menopause. * Under 35 years of age * Over 42 years of age
💊

What it tests

  • oPRP
  • Placebo- Serum
📍

Where

1 site
Generation Next Fertility
New York, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy